These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 15474859)
1. New approaches in immunotherapy: allergen vaccination with immunostimulatory DNA. Creticos PS; Chen YH; Schroeder JT Immunol Allergy Clin North Am; 2004 Nov; 24(4):569-81, v. PubMed ID: 15474859 [TBL] [Abstract][Full Text] [Related]
2. Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions. Creticos PS; Lichtenstein LM Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):304-12; discussion 312-3. PubMed ID: 15119051 [TBL] [Abstract][Full Text] [Related]
3. Allergen immunotherapy in asthma: current status and future perspectives. Nagata M; Nakagome K Allergol Int; 2010 Mar; 59(1):15-9. PubMed ID: 20093852 [TBL] [Abstract][Full Text] [Related]
6. Use of CpG oligonucleotides in treatment of asthma and allergic disease. Fonseca DE; Kline JN Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442 [TBL] [Abstract][Full Text] [Related]
7. DNA-based approaches to the treatment of allergies. Spiegelberg HL; Raz E Curr Opin Mol Ther; 2002 Feb; 4(1):64-71. PubMed ID: 11883696 [TBL] [Abstract][Full Text] [Related]
8. DNA-based immunotherapeutics for the treatment of allergic disease. Horner AA; Van Uden JH; Zubeldia JM; Broide D; Raz E Immunol Rev; 2001 Feb; 179():102-18. PubMed ID: 11292014 [TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory sequences in immunotherapy. Blanks DA Curr Opin Otolaryngol Head Neck Surg; 2007 Aug; 15(4):281-5. PubMed ID: 17620904 [TBL] [Abstract][Full Text] [Related]
10. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081 [TBL] [Abstract][Full Text] [Related]
11. Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy. Spiegelberg HL; Horner AA; Takabayashi K; Raz E Curr Opin Allergy Clin Immunol; 2002 Dec; 2(6):547-51. PubMed ID: 14752340 [TBL] [Abstract][Full Text] [Related]
12. Allergen immunotherapy: where is it now? Nelson HS J Allergy Clin Immunol; 2007 Apr; 119(4):769-79. PubMed ID: 17337297 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis. Amaral CC; Garcia IP; Fernandes GF; Almeida SR; Camargo ZP; Souza MC Scand J Immunol; 2005 Oct; 62(4):325-33. PubMed ID: 16253119 [TBL] [Abstract][Full Text] [Related]
14. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model. Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083 [TBL] [Abstract][Full Text] [Related]
15. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280 [TBL] [Abstract][Full Text] [Related]